Clinical trial
An Extension of Istradefylline in Parkinson's Disease Patients Who Have…
NCT00199368 · Kyowa Kirin, Inc., Industry · Completed
Key facts
| NCT number | NCT00199368 |
|---|---|
| Title | An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018 |
| Official title | A Long-Term, Multicenter, Open-Label Safety Study With Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa Therapy. |
| Lead sponsor | Kyowa Kirin, Inc., Industry |
| Collaborators | Kyowa Hakko Kirin UK, Ltd. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Istradefylline ( KW-6002) |
| Enrollment | 1,100 |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 25, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: